Retractable Technologies, Inc. (RVP)
0.576
-0.02
(-3.84%)
USD |
NYAM |
Nov 20, 14:03
Retractable Technologies Shareholders Equity (Quarterly) : 70.45M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 70.45M |
| June 30, 2026 | 72.87M |
| March 31, 2026 | 70.09M |
| December 31, 2025 | 74.38M |
| September 30, 2025 | 76.78M |
| June 30, 2025 | 76.47M |
| March 31, 2025 | 76.61M |
| December 31, 2024 | 87.17M |
| September 30, 2024 | 83.46M |
| June 30, 2024 | 85.44M |
| March 31, 2024 | 99.66M |
| December 31, 2023 | 99.29M |
| September 30, 2023 | 99.42M |
| June 30, 2023 | 103.54M |
| March 31, 2023 | 107.47M |
| December 31, 2022 | 106.54M |
| September 30, 2022 | 108.98M |
| June 30, 2022 | 102.50M |
| March 31, 2022 | 105.32M |
| December 31, 2021 | 99.17M |
| September 30, 2021 | 79.60M |
| June 30, 2021 | 74.64M |
| March 31, 2021 | 67.84M |
| December 31, 2020 | 49.88M |
| September 30, 2020 | 39.12M |
| Date | Value |
|---|---|
| June 30, 2020 | 33.05M |
| March 31, 2020 | 28.74M |
| December 31, 2019 | 28.54M |
| September 30, 2019 | 26.74M |
| June 30, 2019 | 25.77M |
| March 31, 2019 | 25.43M |
| December 31, 2018 | 25.61M |
| September 30, 2018 | 25.82M |
| June 30, 2018 | 25.94M |
| March 31, 2018 | 26.94M |
| December 31, 2017 | 27.17M |
| September 30, 2017 | 28.34M |
| June 30, 2017 | 27.71M |
| March 31, 2017 | 28.88M |
| December 31, 2016 | 28.11M |
| September 30, 2016 | 30.07M |
| June 30, 2016 | 30.16M |
| March 31, 2016 | 30.06M |
| December 31, 2015 | 31.03M |
| September 30, 2015 | 32.07M |
| June 30, 2015 | 32.36M |
| March 31, 2015 | 25.77M |
| December 31, 2014 | 26.83M |
| September 30, 2014 | 25.95M |
| June 30, 2014 | 25.53M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.03B |
| AngioDynamics, Inc. | 163.96M |
| Alphatec Holdings, Inc. | 21.30M |
| AtriCure, Inc. | 533.22M |
| Baxter International, Inc. | 6.502B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.55M |
| Total Liabilities (Quarterly) | 68.10M |
| Debt to Equity Ratio | 0.0105 |
| Current Ratio | 4.542 |
| Net Debt Paydown Yield | 0.33% |